Advertisement
Advertisement
RNXT
RenovoRx, Inc. Common Stock
0.95
USDSponsored
+0.04
+4.64%
Jun 24, 16:00 UTC -4
Closed
After-Market
0.93
-0.02
-2.20%
RNXT Earnings Reports
Positive Surprise Ratio
RNXT beat 12 of 19 last estimates.
63%
Next Report
Date of Next Report
Aug 12, 2026
Estimate for Q2 26 (Revenue/ EPS)
$653.82K
/-$0.07
Implied change from Q1 26 (Revenue/ EPS)
+16.13%
/-22.22%
Implied change from Q2 25 (Revenue/ EPS)
+54.93%
/-12.50%
RenovoRx, Inc. Common Stock earnings per share and revenue
On May 14, 2026, RNXT reported earnings of -0.09 USD per share (EPS) for Q1 26, missing the estimate of -0.08 USD, resulting in a -10.29% surprise. Revenue reached 563.00 thousand, compared to an expected 472.51 thousand, with a 19.15% difference. The market reacted with a -4.09% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 5 analysts forecast an EPS of -0.07 USD, with revenue projected to reach 653.82 thousand USD, implying an decrease of -22.22% EPS, and increase of 16.13% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
Prenetics Global Limited Class A Ordinary Share
Report Date
Jun 10, 2026 For Q1 26
Estimate
-$1.10
Actual
-$1.61
Surprise
-45.36%
Anixa Biosciences, Inc.
Report Date
Jun 10, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.07
Surprise
+21.61%
FAQ
What were RenovoRx, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, RenovoRx, Inc. Common Stock reported EPS of -$0.09, missing estimates by -10.29%, and revenue of $563.00K, 19.15% above expectations.
How did the market react to RenovoRx, Inc. Common Stock's Q1 2026 earnings?
The stock price moved down -4.09%, changed from $0.85 before the earnings release to $0.82 the day after.
When is RenovoRx, Inc. Common Stock expected to report next?
The next earning report is scheduled for Aug 12, 2026.
What are the forecasts for RenovoRx, Inc. Common Stock's next earnings report?
Based on 5
analysts, RenovoRx, Inc. Common Stock is expected to report EPS of -$0.07 and revenue of $653.82K for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement